Search

CET and skills guides

Study and gain CET points through OT’s online CET exams, and access archived CET, CPD articles and skills guides in our education library

Find out more

Science and vision

News and features about the latest scientific developments and advances in optometry, ophthalmology and eye medicine

Find out more

Industry

News and features about the latest developments in optics with a focus on industry

Find out more

Professional support

News and features about the latest developments relating to professional support from across optics. This includes updates from optical organisations such as the AOP and the GOC

Find out more

In practice

News and in-depth features about business management and career development in optics

Find out more

Jobs

Explore the latest UK and global jobs in the optical sector for optometrists, dispensing opticians and more

Find out more

Potential of sight-saving drugs for AMD patients explored

Funding for research has been announced during Macular Week

Scientist
Scientists at Queen’s University Belfast have secured funding from Fight for Sight to explore the potential of drugs that could prevent or slow down sight loss for patients living with age-related macular degeneration (AMD).

The research, which has been announced during Macular Week (24–30 June), will investigate if the drugs can boost the capacity of blood vessels to repair themselves in the back of the eye.

Professor Alan Stitt (pictured), Dr Reinhold Medina and Dr Imre Lengyel will lead the research into the potential of the drugs for AMD patients, with clinical trials already being carried out for other conditions such as stroke.

Speaking about the research, Professor Stitt said: “Our hope is that our work could lead to an entirely new, exciting and beneficial treatment for patients with this type of AMD where there are few current options.”

Director of policy and innovation at Fight for Sight, Dr Neil Ebenezer, added: “We’re delighted to announce funding for this project and what better time than at the start of Macular Week 2019.”